Upload
honeyworks
View
213
Download
0
Embed Size (px)
DESCRIPTION
med
Citation preview
First-line agentsThe mainstays of treatment for ascariasis are the benzimidazoles,albendazole(400 mg orally once) andmebendazole(100 mg twice daily for three days or 500 mg as a single dose) [47]. A single dose of albendazole is effective in almost 100 percent of cases [48,49]. If other intestinal helminth infections (ie, hookworm, trichuris) may be present, a three-day course of albendazole is efficacious for treatment of concomitant infections [50,51].Both the three-daymebendazoleregimen and the single-dose mebendazole regimen are approximately 95 percent effective [52,53]. A meta-analysis including 20 randomized trials demonstrated high cure rates with single doses ofalbendazoleand mebendazole [50]. Similar results and good tolerability have been described in other studies [52,54-56]. Adverse effects of the benzimidazoles include transient gastrointestinal (GI) discomfort, headache, and, rarely, leukopenia.For treatment of pregnant women,pyrantel pamoateshould be used, given possible teratogenic effects due to the benzimidazoles [50]. Pyrantel pamoate (11mg/kgup to a maximum of 1 g) is administered as a single dose. The efficacy varies with worm load; single-dose therapy is approximately 90 percent effective in eradicating adult worms [3]. Adverse effects include gastrointestinal disturbances, headaches, rash, and fever.